0000899243-23-004063.txt : 20230206 0000899243-23-004063.hdr.sgml : 20230206 20230206171826 ACCESSION NUMBER: 0000899243-23-004063 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230202 FILED AS OF DATE: 20230206 DATE AS OF CHANGE: 20230206 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SOUTHWELL DAVID P CENTRAL INDEX KEY: 0001251553 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40603 FILM NUMBER: 23591576 MAIL ADDRESS: STREET 1: C/O INOTEK PHARMACEUTICALS CORPORATION STREET 2: 91 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TScan Therapeutics, Inc. CENTRAL INDEX KEY: 0001783328 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 825282075 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 880 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 857-399-9500 MAIL ADDRESS: STREET 1: 880 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-02-02 0 0001783328 TScan Therapeutics, Inc. TCRX 0001251553 SOUTHWELL DAVID P C/O TSCAN THERAPEUTICS, INC. 830 WINTER STREET WALTHAM, MA 02451 1 1 0 0 Chief Executive Officer Stock Option (Right to Buy) 1.81 2023-02-02 4 A 0 100000 0.00 A 2033-02-01 Voting Common Stock 100000 100000 D The shares subject to this option vest over 4 years of service following February 2, 2023, with 25% vesting upon completion of 1 year of continuous service to the Issuer and the balance vesting in 36 equal monthly installments thereafter. /s/ David P. Southwell 2023-02-06